• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?

作者信息

Crump Michael

机构信息

Princess Margaret Hospital, Toronto, Canada.

出版信息

Leuk Lymphoma. 2006 Dec;47(12):2437-9. doi: 10.1080/10428190601043278.

DOI:10.1080/10428190601043278
PMID:17169786
Abstract
摘要

相似文献

1
What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?
Leuk Lymphoma. 2006 Dec;47(12):2437-9. doi: 10.1080/10428190601043278.
2
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.以吉西他滨、阿糖胞苷和顺铂联合利妥昔单抗对比单纯吉西他滨、阿糖胞苷和顺铂作为复发或难治性弥漫性大B细胞淋巴瘤患者挽救治疗的配对分析。
Leuk Lymphoma. 2006 Dec;47(12):2558-66. doi: 10.1080/10428190600926572.
3
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.地塞米松、大剂量阿糖胞苷和顺铂联合利妥昔单抗作为复发或难治性侵袭性非霍奇金淋巴瘤患者的挽救治疗方案。
Cancer Invest. 2006 Oct;24(6):593-600. doi: 10.1080/07357900600814490.
4
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome.R-ESHAP方案作为复发或难治性弥漫性大B细胞淋巴瘤患者的挽救治疗：既往自体干细胞移植对疗效的影响。
Haematologica. 2009 May;94(5):744. doi: 10.3324/haematol.2009.006452. Epub 2009 Mar 31.
5
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.
Clin Lymphoma. 2005 Jun;6(1):56-60. doi: 10.3816/clm.2005.n.030.
6
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.奥沙利铂为基础的化疗（地塞米松、高剂量阿糖胞苷和奥沙利铂）±利妥昔单抗是复发或难治性淋巴瘤患者的有效挽救治疗方案。
Cancer. 2010 Oct 1;116(19):4573-9. doi: 10.1002/cncr.25216.
7
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.R-ESHAP方案作为复发或难治性弥漫性大B细胞淋巴瘤患者的挽救治疗：既往使用利妥昔单抗对疗效的影响。一项GEL/TAMO研究。
Haematologica. 2008 Dec;93(12):1829-36. doi: 10.3324/haematol.13440. Epub 2008 Oct 22.
8
Efficacy and safety of modified rituximab-ESHAP therapy for relapsed/refractory B-cell lymphoma.改良利妥昔单抗-ESHAP疗法治疗复发/难治性B细胞淋巴瘤的疗效与安全性
J Chemother. 2010 Feb;22(1):54-7. doi: 10.1179/joc.2010.22.1.54.
9
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.生发中心/活化 B 细胞亚类对复发/难治性弥漫性大 B 细胞淋巴瘤挽救治疗反应的预后影响：一项生物 CORAL 研究。
J Clin Oncol. 2011 Nov 1;29(31):4079-87. doi: 10.1200/JCO.2011.35.4423. Epub 2011 Sep 26.
10
Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.伊立替康联合顺铂和地塞米松（ICD）方案化疗用于先前接受过利妥昔单抗联合CHOP方案治疗的弥漫性大B细胞淋巴瘤患者。
Cancer Chemother Pharmacol. 2008 Jul;62(2):299-304. doi: 10.1007/s00280-007-0607-4. Epub 2007 Oct 9.